Spermosens is commercializing the first functional male infertility diagnostic device to directly predict the fusion capacity of sperms. Using recombinant proteins, nanotechnology and electrochemistry, the novel diagnostic device will help patients and healthcare providers to probe the underlying cause of unexplained male infertility, and to select the appropriate IVF treatment.